참고문헌 (20)

1. Yoon SK. Diagnosis and treatment of fatty liver. Korean J Med 2009;76(6):677-9. 

2. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases. Hepatology 2018;67(1):328-57. 

3. Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 2017;377(21):2063-72. 

   상세보기

4. Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, et al. KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2021;27(3):363-401. 

   상세보기

5. Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic Steatohepatitis: A Review. JAMA 2020;323(12):1175-83. 

   상세보기

6. Jarvis H, Craig D, Barker R, Spiers G, Stow D, Anstee QM, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLoS Med 2020;17(4):e1003100. 

   상세보기

7. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 2010;51(2):679-89. 

8. Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016;65(8):1109-23. 

   상세보기

9. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010;42(7):503-8. 

10. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002;17 Suppl: S186-90. 

11. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64(1):73-84. 

12. Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism 2019;92:82-97. 

    상세보기

13. Milic S, Lulic D, Stimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol 2014;20(28):9330-7. 

    상세보기

14. Reginato E, Pippi R, Aiello C, Sbroma Tomaro E, Ranucci C, Buratta L, et al. Effect of short term intensive lifestyle intervention on hepatic steatosis indexes in adults with obesity and/or type 2 diabetes. J Clin Med 2019;8(6):851. 

    상세보기

15. Sorrentino G, Crispino P, Coppola D, De Stefano G. Efficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical: a controlled clinical study. Drugs R D 2015;15(1):21-5. 

16. Woo HJ, Lee JH, Kim YC, Kim GS, Son CK, Jo JH, et al. Oriental Internal Medicine on Hepatobiliary System, Hematology and Toxicology 6th. Seoul: Nado; 2016, p. 307-15. 

17. Kim BW. Clinical analysis and the effect of Saenggangunbitang on 3,136 cases of the chronicle hepatitis patients. The Journal of Korean Oriental Medicine 1993;14(1):216-23. 

18. Kim HY, Joo SH, Bae JH, Jang EG, Kim YC, Lee JH. A case report of nonalcoholic steatohepatitis with metabolic Syndrome. J Int Korean Med 2017;38(2):125-30. 

19. Yang HJ, Park JK, Kwon SY, Woo HJ, Lee JH, Kim YC. A clinical study of 5 cases of patients who have nonalcoholic fatty liver disease(NAFLD) treated by Saenggangeonbi-tang. J Int Korean Med 2011;spr(1):141-51. 

20. Choi ES, Kim HY, Cho YH, Jang EG, Woo HJ, Kim YC, et al. A case report of adolescent nonalcoholic fatty liver disease (NAFLD) with severe obesity. J Int Korean Med 2015;spr(1):89-95. 

저자의 다른 논문 :

장은경 (19) 이장훈 (85)